ArticleCadernos de saude publica2025
SARS-CoV-2 infection in the Indigenous Pataxó community of Southern Bahia, Brazil: second wave of transmission and vaccine effects.
Article in Cadernos de saude publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Indigenous people are at risk of several infectious diseases, including viruses that affect the respiratory system. In a previous study, we demonstrated how the Pataxó ethnic group, in the southernmost region of Bahia State, Brazil, was disproportionately affected during the first wave of COVID-19. Here, we provide an overview of how this community was affected by the second wave of the disease, evaluating the impact of vaccination on SARS-CoV-2 transmission. Prospective study data was grouped by Epidemiological Weeks 3/2021-43/2022, during which vaccine effects were analyzed and new variants of concern (VOC) emerged. The second wave produced a decreasing trimodal moving average curve, with an incidence rate of 4,407.2/100,000 inhabitants. Mobility and precarious work situations linked to tourism and craft trade increased infection rates in some villages. Risk factors for infection and severity (female sex, older age, and comorbidities) were determinants, but mortality was lower. Individuals with two doses of vaccine (Vac) developed more symptoms than the unvaccinated, but were less likely to have dyspnea. The mean time for COVID-19 symptoms to develop was longer in those with Vac (x̅ = 27 weeks) compared to those who received only one dose (x̅ = 12 weeks, p ≤ 0.001). Vac individuals who received booster shots, VacB1 and VacB2, had infection rates of 7.4% and 0%, respectively. The detrimental impact of COVID-19 once again highlights the persistence of health and socioeconomic inequities in this ethnic group. Moreover, the vaccines failed to prevent transmission, possibly due to mutated VOCs, but they may have protected this group against severe symptoms and extended the transmission period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.